Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2

Abstract

Motility-related protein-1 (MRP-1/CD9) is involved in cell motility. We studied the change in the actin cytoskeleton, and the expression of actin-related protein (Arp) 2 and Arp3 and the Wiskott–Aldrich syndrome protein (WASP) family according to MRP-1/CD9 gene transduction into HT1080 cells. The frequency of cells with lamellipodia was significantly lower in MRP-1/CD9-transfected HT1080 cells than in control HT1080 cells (P<0.0001). MRP-1/CD9 gene transduction affected the subcellular localization of Arp2 and Arp3 proteins. Furthermore, MRP-1/CD9 gene transduction induced a downregulation of WAVE2 expression (P<0.0001). However, no difference was observed in the expression of Arp2, Arp3 or other WASPs. A neutralizing anti-MRP-1/CD9 monoclonal antibody inhibited downregulation of WAVE2 in MRP-1/CD9-transfected HT1080 cells (P<0.0001), and reversed the morphological effects of MRP-1/CD9 gene transduction. Furthermore, downregulation of WAVE2 by transfection of WAVE2-specific small interfering RNA (siRNA) mimicked the morphological effects of MRP-1/CD9 gene transduction and suppressed cell motility. However, transfection of each siRNA for Wnt1, Wnt2b1 or Wnt5a did not affect WAVE2 expression. Transfection of WAVE2-specific siRNA also did not affect expressions of these Wnts. These results indicate that MRP-1/CD9 regulates the actin cytoskeleton by downregulating of the WAVE2, through the Wnt-independent signal pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bailly M, Macaluso F, Cammer M, Chan A, Segall JE, Condeelis JS . (1999). J Cell Biol 145: 331–345.

  • Berditchevski F, Odintsova E. . (1999). J Cell Biol 146: 477–492.

  • Charrin S, Le Naour F, Oualid M, Billard M, Faure G, Hanash SM et al. (2001). J Biol Chem 276: 14329–14337.

  • Chen HC, Appeddu PA, Isoda H, Guan JL . (1996). J Biol Chem 271: 26329–26334.

  • Condeelis JS, Wyckoff JB, Bailly M, Pestell R, Lawrence D, Backer J et al. (2001). Semin Cancer Biol 11: 119–128.

  • Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW . (2002). Nature 418: 790–793.

  • Gutierrez-Lopez MD, Ovalle S, Yanez-Mo M, Sanchez-Sanchez N, Rubinstein E, Olmo N et al. (2003). J Biol Chem 278: 208–218.

  • Hall A . (1998). Science 279: 509–514.

  • Higashiyama M, Taki T, Ieki Y, Adachi M, Huang C, Koh T et al. (1995). Cancer Res 55: 6040–6044.

  • Huang C, Kohno N, Ogawa E, Adachi M, Taki T, Miyake M . (1998). Am J Pathol 153: 973–983.

  • Huang C, Liu D, Masuya D, Kameyama K, Nakashima T, Yokomise H et al. (2004). Oncogene 23: 7475–7483.

  • Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M . (1993). J Exp Med 177: 1231–1237.

  • King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS . (1997). Mol Cell Biol 17: 4406–4418.

  • Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T . (2005). Oncogene 24: 1309–1319.

  • Le Naour F, Charrin S, Labas V, Le Caer JP, Boucheix C, Rubinstein E . (2004). Cancer Immunol Immunother 53: 148–152.

  • Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC et al. (1999). Proc Natl Acad Sci USA 96: 3739–3744.

  • Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A et al. (1999). Science 285: 895–898.

  • Miki H, Suetsugu S, Takenawa T . (1998). EMBO J 17: 6932–6941.

  • Miyake M, Koyama M, Seno M, Ikeyama S . (1991). J Exp Med 174: 1347–1354.

  • Miyake M, Inufusa H, Adachi M, Ishida H, Hashida H, Tokuhara T et al. (2000). Oncogene 19: 5221–5226.

  • Park KR, Inoue T, Ueda M, Hirano T, Higuchi T, Konishi I et al. (2000). Mol Hum Reprod 6: 719–725.

  • Rohatgi R, Ho HH, Kirschner MW . (2000). J Cell Biol 150: 1299–1309.

  • Soderling SH, Langeberg LK, Soderling JA, Davee SM, Simerly R, Raber J et al. (2003). Proc Natl Acad Sci USA 100: 1723–1728.

  • Stipp CS, Kolesnikova TV, Hemler ME . (2001). J Biol Chem 276: 40545–40554.

  • Suetsugu S, Yamazaki D, Kurisu S, Takenawa T . (2003). Dev Cell 5: 595–609.

  • Takenawa T, Miki H . (2001). J Cell Sci 114: 1801–1809.

  • Vartiainen MK, Machesky LM . (2004). Curr Opin Cell Biol 16: 174–181.

  • Yamaguchi H, Miki H, Suetsugu S, Ma L, Kirschner MW, Takenawa T . (2000). Proc Natl Acad Sci USA 97: 12631–12636.

  • Yamazaki D, Suetsugu S, Miki H, Kataoka Y, Nishikawa S, Fujiwara T et al. (2003). Nature 424: 452–456.

  • Yan C, Martinez-Quiles N, Eden S, Shibata T, Takeshima F, Shinkura R et al. (2003). EMBO J 22: 3602–3612.

  • Yauch RL, Hemler ME . (2000). Biochem J 351: 629–637.

  • Zhang XA, Bontrager AL, Hemler ME . (2001). J Biol Chem 276: 25005–25013.

  • Zhu B, Ping G, Shinohara Y, Zhang Y, Baba Y . (2005). Genomics 85: 657–665.

  • Zilber MT, Setterblad N, Vasselon T, Doliger C, Charron D, Mooney N et al. (2005). Blood 106: 3074–3081.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C-L Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, CL., Ueno, M., Liu, D. et al. MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2. Oncogene 25, 6480–6488 (2006). https://doi.org/10.1038/sj.onc.1209654

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1209654

Keywords

This article is cited by

Search

Quick links